Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 23, 2004
- Accepted April 25, 2005
- Published online May 1, 2005.
Copyright & Usage
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- MALGORZATA WASOWSKA1,
- IRENA OSZCZAPOWICZ1,
- JOANNA WIETRZYK2,
- ADAM OPOLSKI2,
- JANUSZ MADEJ3,
- STANISLAW DZIMIRA3 and
- JANUSZ OSZCZAPOWICZ4
- 1Institute of Biotechnology and Antibiotics, 5 Staroscinska Str., 02-516 Warsaw
- 2Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, 12 Weigla Str., 53-114 Wroclaw
- 3Faculty of Veterinary Medicine Agriculture University, 31 Norwida Str., 50-375 Wroclaw
- 4Department of Chemistry, Warsaw University, 1 Pasteura Str., 02-093 Warsaw, Poland
- Correspondence to: Malgorzata Wasowska, M.Sc., Department of Modified Antibiotics, Institute of Biotechnology and Antibiotics, 5 Staroscinska St., 02-516 Warsaw, Poland. Tel: 4822/8496051 ext. 230 or 260, Fax: 4822/8483332, e-mail: wasowskam{at}iba.waw.pl
Statistics from Altmetric.com
Cited By...
Jump to section
Related Articles
Cited By...
- In Vitro Antileukemic Activity of Formamidine Epidoxorubicin Analogs
- Formamidinodoxorubicins Are more Potent than Doxorubicin as Apoptosis Inducers in Human Breast Cancer Cells
- Cell-cycle Disturbance and Induction of Programmed Death by New Formamidine Analogs of Daunorubicin
- In Vitro Induction of Apoptosis and Necrosis by New Derivatives of Daunorubicin
- Effects of Structural Modifications of Daunorubicin on In Vitro Antileukemic Activity
- Oxazolinodoxorubicin - a Promising New Anthracycline
- Cytotoxicity and Cellular Uptake of Doxorubicin and its Formamidine Derivatives in HL60 Sensitive and HL60/MX2 Resistant Cells